Two panels of plasma microRNAs as non-invasive biomarkers for prediction of recurrence in resectable NSCLC.
The diagnosis of non-small cell lung carcinoma (NSCLC) at an early stage, as well as better prediction of outcome remains clinically challenging due to the lack of specific and robust non-invasive markers. The discovery of microRNAs (miRNAs), particularly those found in the bloodstream, has opened u...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3546982?pdf=render |
id |
doaj-a6c2a986eb10421ea387691d61dd7357 |
---|---|
record_format |
Article |
spelling |
doaj-a6c2a986eb10421ea387691d61dd73572020-11-25T01:13:35ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-0181e5459610.1371/journal.pone.0054596Two panels of plasma microRNAs as non-invasive biomarkers for prediction of recurrence in resectable NSCLC.Céline SanfiorenzoMarius I IlieAmine BelaidFabrice BarlésiJérôme MourouxCharles-Hugo MarquettePatrick BrestPaul HofmanThe diagnosis of non-small cell lung carcinoma (NSCLC) at an early stage, as well as better prediction of outcome remains clinically challenging due to the lack of specific and robust non-invasive markers. The discovery of microRNAs (miRNAs), particularly those found in the bloodstream, has opened up new perspectives for tumor diagnosis and prognosis. The aim of our study was to determine whether expression profiles of specific miRNAs in plasma could accurately discriminate between NSCLC patients and controls, and whether they are able to predict the prognosis of resectable NSCLC patients. We therefore evaluated a series of seventeen NSCLC-related miRNAs by quantitative real-time (qRT)-PCR in plasma from 52 patients with I-IIIA stages NSCLC, 10 patients with chronic obstructive pulmonary disease (COPD) and 20-age, sex and smoking status-matched healthy individuals. We identified an eleven-plasma miRNA panel that could distinguish NSCLC patients from healthy subjects (AUC = 0.879). A six-plasma miRNA panel was able to discriminate between NSCLC patients and COPD patients (AUC = 0.944). Furthermore, we identified a three-miRNA plasma signature (high miR-155-5p, high miR-223-3p, and low miR-126-3p) that significantly associated with a higher risk for progression in adenocarcinoma patients. In addition, a three-miRNA plasma panel (high miR-20a-5p, low miR-152-3p, and low miR-199a-5p) significantly predicted survival of squamous cell carcinoma patients. In conclusion, we identified two plasma miRNA expression profiles that may be useful for predicting the outcome of patients with resectable NSCLC.http://europepmc.org/articles/PMC3546982?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Céline Sanfiorenzo Marius I Ilie Amine Belaid Fabrice Barlési Jérôme Mouroux Charles-Hugo Marquette Patrick Brest Paul Hofman |
spellingShingle |
Céline Sanfiorenzo Marius I Ilie Amine Belaid Fabrice Barlési Jérôme Mouroux Charles-Hugo Marquette Patrick Brest Paul Hofman Two panels of plasma microRNAs as non-invasive biomarkers for prediction of recurrence in resectable NSCLC. PLoS ONE |
author_facet |
Céline Sanfiorenzo Marius I Ilie Amine Belaid Fabrice Barlési Jérôme Mouroux Charles-Hugo Marquette Patrick Brest Paul Hofman |
author_sort |
Céline Sanfiorenzo |
title |
Two panels of plasma microRNAs as non-invasive biomarkers for prediction of recurrence in resectable NSCLC. |
title_short |
Two panels of plasma microRNAs as non-invasive biomarkers for prediction of recurrence in resectable NSCLC. |
title_full |
Two panels of plasma microRNAs as non-invasive biomarkers for prediction of recurrence in resectable NSCLC. |
title_fullStr |
Two panels of plasma microRNAs as non-invasive biomarkers for prediction of recurrence in resectable NSCLC. |
title_full_unstemmed |
Two panels of plasma microRNAs as non-invasive biomarkers for prediction of recurrence in resectable NSCLC. |
title_sort |
two panels of plasma micrornas as non-invasive biomarkers for prediction of recurrence in resectable nsclc. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2013-01-01 |
description |
The diagnosis of non-small cell lung carcinoma (NSCLC) at an early stage, as well as better prediction of outcome remains clinically challenging due to the lack of specific and robust non-invasive markers. The discovery of microRNAs (miRNAs), particularly those found in the bloodstream, has opened up new perspectives for tumor diagnosis and prognosis. The aim of our study was to determine whether expression profiles of specific miRNAs in plasma could accurately discriminate between NSCLC patients and controls, and whether they are able to predict the prognosis of resectable NSCLC patients. We therefore evaluated a series of seventeen NSCLC-related miRNAs by quantitative real-time (qRT)-PCR in plasma from 52 patients with I-IIIA stages NSCLC, 10 patients with chronic obstructive pulmonary disease (COPD) and 20-age, sex and smoking status-matched healthy individuals. We identified an eleven-plasma miRNA panel that could distinguish NSCLC patients from healthy subjects (AUC = 0.879). A six-plasma miRNA panel was able to discriminate between NSCLC patients and COPD patients (AUC = 0.944). Furthermore, we identified a three-miRNA plasma signature (high miR-155-5p, high miR-223-3p, and low miR-126-3p) that significantly associated with a higher risk for progression in adenocarcinoma patients. In addition, a three-miRNA plasma panel (high miR-20a-5p, low miR-152-3p, and low miR-199a-5p) significantly predicted survival of squamous cell carcinoma patients. In conclusion, we identified two plasma miRNA expression profiles that may be useful for predicting the outcome of patients with resectable NSCLC. |
url |
http://europepmc.org/articles/PMC3546982?pdf=render |
work_keys_str_mv |
AT celinesanfiorenzo twopanelsofplasmamicrornasasnoninvasivebiomarkersforpredictionofrecurrenceinresectablensclc AT mariusiilie twopanelsofplasmamicrornasasnoninvasivebiomarkersforpredictionofrecurrenceinresectablensclc AT aminebelaid twopanelsofplasmamicrornasasnoninvasivebiomarkersforpredictionofrecurrenceinresectablensclc AT fabricebarlesi twopanelsofplasmamicrornasasnoninvasivebiomarkersforpredictionofrecurrenceinresectablensclc AT jeromemouroux twopanelsofplasmamicrornasasnoninvasivebiomarkersforpredictionofrecurrenceinresectablensclc AT charleshugomarquette twopanelsofplasmamicrornasasnoninvasivebiomarkersforpredictionofrecurrenceinresectablensclc AT patrickbrest twopanelsofplasmamicrornasasnoninvasivebiomarkersforpredictionofrecurrenceinresectablensclc AT paulhofman twopanelsofplasmamicrornasasnoninvasivebiomarkersforpredictionofrecurrenceinresectablensclc |
_version_ |
1725161358443413504 |